Similarly, the general population showed no reduction in deaths due to ovarian cancer in screened women compared with those who were not screened.45 Although ovarian cancer screening showed a stage shift in those at elevated risk,30 these were mostly in BRCA1/2 carriers who have a higher penetrance for ovarian cancer compared with mismatch repair carriers. This evidence concerns the gene BRCA1 and ovarian cancer.